The company's largest shareholder

Novo Holdings A/S is a leading international life science investor and the holding company of the Novo Group. It is wholly owned by the Novo Nordisk Foundation and serves as the largest shareholder of Novo Nordisk and Novozymes. The firm manages the foundation's assets through a broad range of investments, including seed and venture capital for early-stage biotech companies, as well as significant stakes in established life science firms. Novo Holdings is a key player in the global healthcare ecosystem, providing long-term capital and strategic support to companies developing innovative therapies and technologies. Its investment activities are divided into several areas, including Novo Seeds, Novo Capital, and Novo Principal Investments.